Tryptophan pyrrolase activity has been determined inBombyx mori rb in daily intervals using two different methods. Separation of kynurenine by electrophoresis and fluorimetric determination proved to be more reliable than estimation by the Bratton-Marshall procedure. 1. Maximal activity in vitro is obtained at pH 8.5 and 1.2 to 2.4 mM tryptophan. The enzyme is inhibited by higher substrate concentration. 2. In the fat body the specific activity of the enzyme follows a U-curve; it drops prior to spinning. In the gut wall, activity is detected with certainty only up to the time of pupation. In testes and ovaries the specific activity drops continuously through metamorphosis, while in developing ovaries the absolute activity increases considerably. During wing development the activity is high, but vanishes at the end of differentiation. No activity was found in Malpighian tubules, in the spinning gland, in the pupal gut, and in the eyes. There are no conclusive results for epidermal tissue, whereas muscle and nervous tissue have not been assayed at all. 2. At the onset of metamorphosis the low tryptophan pyrrolase activity is a limiting factor in tryptophan degradation. Tryptophan therefore increases strongly for a short time. From a comparison of developmental patterns of both tryptophan pyrrolase and kynurenine hydroxylase it is concluded that both enzymes are subject to independent regulation. It is postulated that their corresponding genes are localized in different regions of the genome which are of secondary importance and thus are transcribed according to local developmental programs only.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF00582928DOI Listing

Publication Analysis

Top Keywords

tryptophan pyrrolase
16
activity
9
pyrrolase activity
8
specific activity
8
tryptophan
7
[autonomous behaviour
4
behaviour tryptophan-degrading
4
tryptophan-degrading enzymes
4
enzymes metamorphosis
4
metamorphosis ofbombyx
4

Similar Publications

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer, originating from the malignant proliferation of squamous epithelial cells. However, its pathogenesis remains unclear. To further explore the mechanisms underlying cSCC, we analyzed the data from one single-cell RNA sequencing study and discovered a significant upregulation of tryptophan 2,3-dioxygenase (TDO2) in the cancer-associated fibroblasts (CAFs).

View Article and Find Full Text PDF

Pyrrolnitrin, a potent antifungal compound originally discovered in Pseudomonas strains, is biosynthesized through a secondary metabolic pathway involving four key enzymes. Central to this process is PrnB, a heme enzyme that catalyzes the complex transformation of 7-Cl-L-tryptophan. Despite its structural similarity to indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase and its classification within the histidine-ligated heme-dependent aromatic oxygenase superfamily, PrnB has remained relatively unexplored due to the challenges in reconstituting its in vitro activity.

View Article and Find Full Text PDF
Article Synopsis
  • Substance use disorder (SUD) is a major public health issue in the U.S., linked to rising overdose deaths and prescription drug misuse, highlighting the need to explore its molecular and genetic roots.
  • The study utilized the All of Us cohort to analyze genetic variants in four genes related to the kynurenine pathway across six groups, including various types of substance use disorders.
  • Results indicated significant genetic variations in 14 out of 18 polymorphisms, with the cocaine group showing the highest number of significant variants, suggesting possible genetic predictors for increased susceptibility to SUD.
View Article and Find Full Text PDF

Discovery and binding mode of small molecule inhibitors of the apo form of human TDO2.

Sci Rep

November 2024

Drug discovery, Idorsia Pharmaceuticals Limited, Hegenheimermattweg 91, Allschwil, Basel-Land, 4123, Switzerland.

Tryptophan-2,3-dioxygenase (TDO2) and indoleamine-2,3-dioxygenase (IDO1) are structurally distinct heme enzymes that catalyze the conversion of L-tryptophan to N-formyl-kynurenine, and play important roles in metabolism, inflammation, and tumor immune surveillance. The enzymes can adopt an inactive, heme-free (apo) state or an active, heme-containing (holo) state, with the balance between them varying dynamically according to biological conditions. Inhibitors of holo-TDO2 are known but, despite several advantages of the heme-free state as a drug target, no inhibitors of apo-TDO2 have been reported.

View Article and Find Full Text PDF

Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer.

Mol Cancer

October 2024

Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.

Article Synopsis
  • * Dysregulated Trp metabolism is linked to various cancers, contributing to tumor growth and immune evasion by creating an immunosuppressive tumor microenvironment (TME) through metabolites like Kyn that influence immune responses and promote cancer development.
  • * Targeting Trp metabolism with small-molecule inhibitors, such as those for IDO1 and TDO, shows promise in restoring anti-tumor immune responses, but mixed clinical trial
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!